Model systems such as patient-derived iPSCs (51, 211, 212), and human hindbrain-derived neuroepithelial stem cells (213) align with the developmental trajectory of the CNS, therefore are likely to reflect a more authentic evolution of the tumour through targeting of relevant oncogenes such as MYCN. The gene discussed is MYCN; the disease is neoplasm.